Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$156K Hold
1,527
﹤0.01% 1078
2025
Q4
$154K Buy
1,527
+297
+24% +$29.3K ﹤0.01% 1031
2025
Q3
$106K Hold
1,230
﹤0.01% 1221
2025
Q2
$94K Sell
1,230
-357
-22% -$26.1K ﹤0.01% 1237
2025
Q1
$113K Hold
1,587
﹤0.01% 1413
2024
Q4
$124K Buy
1,587
+602
+61% +$56.2K ﹤0.01% 1404
2024
Q3
$101K Hold
985
﹤0.01% 1279
2024
Q2
$75K Buy
985
+272
+38% +$19.3K ﹤0.01% 1360
2024
Q1
$54K Hold
713
﹤0.01% 1512
2023
Q4
$52K Buy
+713
New +$44.1K ﹤0.01% 1492

Other funds holding NUVL

KBC Group's NUVL Position: Q1 2026 in Review

KBC Group held its Nuvalent (NUVL) position steady in Q1 2026 at 1,527 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

KBC Group first reported a position in NUVL in Q4 2023 and has held it in 10 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • KBC Group held 1,527 shares of Nuvalent worth $156K as of Q1 2026.
  • KBC Group left its Nuvalent share count unchanged in Q1 2026.
  • Nuvalent made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1078 holding.
  • KBC Group first reported a position in Nuvalent in Q4 2023 and has held it in 10 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.